Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, proudly announces the appointment of Kumar Iyer as Chief Product Officer. In this role, Iyer will spearhead the growth of Eko’s software platform to millions of healthcare providers and thousands of health systems globally.
Iyer brings a distinguished track record of creating and scaling world-class products. At 23andMe, he oversaw product, design, product science, and AI teams, resulting in highly successful subscription offerings. Previously, Iyer held roles at Meta, NVIDIA, and Netflix, where he drove growth, engagement, and product innovation that reached hundreds of millions of users.
"Kumar’s expertise in consumer technology and health perfectly complements Eko’s mission to bring innovative, AI-powered solutions to healthcare professionals," said Connor Landgraf, CEO and co-founder of Eko. "His leadership will accelerate our efforts to scale Eko+, deepen partnerships with health systems, and enhance access to early detection tools that are reshaping the future of cardiopulmonary care."
Eko Health’s recent milestones include FDA clearance for its Low Ejection Fraction (Low EF) AI and the AMA’s granting of a Category III CPT code, solidifying its position as a leader in AI-driven cardiovascular care.
"Eko Health’s technology is at the forefront of transforming how clinicians detect and manage heart and lung diseases," said Kumar Iyer. "I’m thrilled to join a team that is not only innovating but also making a profound difference in patient care. Together, we will ensure these life-changing tools reach clinicians and health systems worldwide."